Clinical trial
Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney…
NCT00002847 · Blumenthal Cancer Center at Carolinas Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00002847 |
|---|---|
| Title | Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer |
| Official title | TREATMENT OF METASTATIC RENAL CELL CARCINOMA WITH SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 AND INTERFERON ALPHA |
| Lead sponsor | Blumenthal Cancer Center at Carolinas Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Biological, Procedure |
| Interventions | aldesleukin, recombinant interferon alfa, conventional surgery |
| Enrollment | 14 |
| Start date | Sep 1, 1995 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: